AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

Recruitingn/aAges 50 Years - 99 YearsAllCentre Integre Universitaire de Sante et Servicesโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The Sonographic Assessment of the Optic Nerve Sheath in Giant Cell Arteritis (SONIC-GCA) study will evaluate the performance of the optic nerve sheath diameter (ONSD), measured via ultrasound, to diagnose and monitor GCA. SONIC-GCA builds upon our previous pilot studies and will answer the following questions: 1. What is the performance of ONSD to identify patients with new-onset, active GCA? 2. Is ONSD useful for monitoring GCA relapses during follow-up? 3. What is the intra- and interobserver reliability of ONSD measurements? 4. Does ONSD differ between patients with and without GCA-related retinal findings?

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Our population of interest is patients referred from any settings for suspected, new-onset GCA. Inclusion criteria: To be included in SONIC-GCA, participants must meet all the following criteria: 1. Age \> 50 years. 2. Referral to a GCA clinic for suspected, new-onset GCA. 3. Ability to understand and willingness to sign an informed consent form. 4. Willingness to comply with study visits and procedures. Exclusion criteria: An individual who meets any of these criteria will be excluded from SONIC-GCA: 1. Referral for a suspected GCA relapse. 2. Current use of systemic glucocorticoids, with the following duration at the baseline visit: โ‰ฅ 14 consecutive days of oral glucocorticoids in the previous 30 days, or โ‰ฅ 7 consecutive days of oral glucocorticoids if intravenous glucocorticoids were administered in the previous 30 days. 3. Current use of any conventional or biologic immunosuppressive therapy. 4. Known previous medical history of retinal diseases, optic nerve diseases, demyelinating diseases, normotensive hydrocephalus, intracranial tumors (benign or malignant), or any conditions associated with intracranial hypertension. 5. Any condition that impairs the ability to perform optic nerve sheath ultrasound or fundoscopy.
๐Ÿ’Š

What it tests

  • Optic nerve sheath ultrasound
  • Standardized GCA assessment
๐Ÿ“

Where

7 sites
St-Joseph's Health Care London
London, Canada
The Ottawa Hospital
Ottawa, Canada
Sinai Health - Toronto
Toronto, Canada
MUHC - McGill University
Montreal, Canada
Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
Montreal, Canada
CIUSSS de l'Est-de-l'ile de Montreal
Montreal, Canada
CIUSSS de l'Estrie - CHUS
Sherbrooke, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy